v3.26.1
Discontinued Operations (Tables)
 6 Months Ended
Mar. 31, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Disposal Groups The following table presents the financial results of the B Medical Systems business, included within discontinued operations (in thousands):
Three Months Ended March 31,Six Months Ended March 31,
2026202520262025
Revenue
Products$19,266 $15,886 $30,280 $30,119 
Services3,527 1,320 5,616 4,678 
Total revenue22,793 17,206 35,896 34,797 
Cost of revenue
Products11,948 10,462 21,266 20,368 
Services3,040 1,071 5,690 5,893 
Total cost of revenue14,988 11,533 26,956 26,261 
Gross profit7,805 5,673 8,940 8,536 
Operating expenses
Research and development1,122 1,201 2,723 2,836 
Selling, general and administrative5,534 7,729 8,903 13,916 
Loss on assets held for sale6,269 31,848 15,965 31,848 
Restructuring charges183 364 299 678 
Total operating expenses13,108 41,142 27,890 49,278 
Operating loss(5,303)(35,469)(18,950)(40,742)
Interest income (expense), net— (15)1 (10)
Other income (expense), net749 (604)1,166 (74)
Loss before income taxes(4,554)(36,088)(17,783)(40,826)
Income tax benefit(917)(8,597)(4,301)(9,416)
Loss from discontinued operations, net of tax$(3,637)$(27,491)$(13,482)$(31,410)
Schedule of Disposal Groups - Non-cash Items
The following table presents the significant non-cash items, capital expenditures and the deposit received from Thelema for the discontinued operations with respect to the B Medical Systems business that are included in the Condensed Consolidated Statements of Cash Flows (in thousands):
Three Months Ended March 31,Six Months Ended March 31,
2026202520262025
Depreciation and amortization$— $— $— $3,846 
Capital expenditures598 371 945 1,128 
Loss on assets held for sale6,269 31,848 15,965 31,848 
Schedule of Disposal Groups - Balance Sheet
The carrying value of the assets and liabilities of the discontinued operations with respect to the B Medical Systems business reflected as “held for sale” on the Condensed Consolidated Balance Sheets as of March 31, 2026 and September 30, 2025 was as follows (in thousands):
March 31, 2026September 30, 2025
Assets
Cash and cash equivalents$8,763 $13,206 
Accounts receivable, net14,345 10,090 
Inventories42,508 42,137 
Prepaid expenses and other current assets11,562 8,102 
Current assets held for sale$77,178 $73,535 
Property, plant and equipment, net$50,697 $50,968 
Intangibles, net123,569 126,065 
Other assets4,805 4,828 
Valuation allowance(110,699)(96,855)
Noncurrent assets held for sale$68,372 $85,006 
Liabilities
Accounts payable$12,166 $11,710 
Deferred revenue3,516 1,543 
Accrued warranty and retrofit costs5,512 5,248 
Accrued compensation and benefits4,584 3,909 
Accrued income taxes740 760 
Accrued expenses and other current liabilities4,898 5,098 
Current liabilities held for sale$31,416 $28,268 
Long-term deferred tax liabilities6,654 9,639 
Long-term operating lease liabilities1,193 2,077 
Other long-term liabilities1,823 2,575 
Noncurrent liabilities held for sale$9,670 $14,291